ERBB2 and breast cancer: However, the fact that the HER-2 positive samples, which are considered to present a worse prognosis than the ER/PR positive and triple positive tumors, presented the second highest HK and PFK activity strengthens the correlation between the enzyme activity and the prognosis for breast cancer patients.